ACADIA Pharmaceuticals Inc.

In News

Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026 - BioSpace

BioSpace - Jul 16, 2026

An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors? - Yahoo Finance

Yahoo Finance - Jul 11, 2026

On second try, Acadia drug gets nod from European regulators - BioPharma Dive

BioPharma Dive - Jun 26, 2026

ACADIA Pharmaceuticals Inc (ACAD) Institutional Confidence - TradingKey

TradingKey - Jul 13, 2026

Acadia Pharmaceuticals: Steady Commercial Progress, Remlifanserin Data In Focus - Seeking Alpha

Seeking Alpha - Jun 29, 2026

Enterprise value to EBITDA forward of ACADIA Pharmaceuticals Inc. – NASDAQ:ACAD - TradingView

TradingView - Jul 05, 2026

ACADIA Pharmaceuticals (ACAD) Stock Looks Undervalued After A 21% Run - simplywall.st

simplywall.st - Jul 09, 2026

H.C. Wainwright Keeps Their Buy Rating on ACADIA Pharmaceuticals (ACAD) - The Globe and Mail

The Globe and Mail - Jul 10, 2026

ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value? - Yahoo Finance

Yahoo Finance - Jul 11, 2026

Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer - BioSpace

BioSpace - Jul 07, 2026

ACADIA Pharmaceuticals: The Song Remains The Same (NASDAQ:ACAD) - Seeking Alpha

Seeking Alpha - Jun 22, 2026

ACADIA Pharmaceuticals Inc. Actuals & Estimates (NASDAQ:ACAD) - TradingView

TradingView - Jun 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment